Population Pharmacokinetics of the Novel Anticancer Agent E7070 During Four Phase I Studies: Model Building and Validation von VAN KESTEREN, Ch, MATHOT, R. A. A, WANDERS, J, BEIJNEN, J. H, FUMOLEAU, P, SCHELLENS, J. H. M, RAYMOND, E, ARMAND, J. P, DITTRICH, Ch, DUMEZ, H, ROCHE, H, DROZ, J. P, PUNT, C, RAVIC, M

Volltext

Pharmacokinetic-pharmacodynamic guided trial design in oncology von van Kesteren, Ch, Mathôt, R A A, Beijnen, J H, Schellens, J H M

Volltext

Pharmacokinetic-pharmacodynamic guided trial design in oncology: Role of modeling and simulation in clinical development of anticancer agents von VAN KESTEREN, Ch, MATHOT, R. A. A, BEIJNEN, J. H, SCHELLENS, J. H. M

Volltext

Population pharmacokinetics and pharmacokinetic‐pharmacodynamic relationships of the novel anticancer agent E7070 in four phase I studies von Van Kesteren, CH, Mathôt, R. A. A., Raymond, E., Armand, J. P., Dittrich, CH, Dumez, H., Roché, H., Droz, J. P., Punt, C., Ravic, M., Wanders, J., Beijnen, J. H., Fumoleau, P., Schellens, J. H. M.

Volltext

Implementation of toxicokinetics in toxicity studies – Toxicokinetics of 4-methylanisole and its metabolites in juvenile and adult rats von Brandon, Esther F.A., van Kesteren, Petra C.E., van Eijkeren, Jan C.H., Tienstra, Marc, Sanchez, Patricia Lopez, Tonk, Elisa C.M., Piersma, Aldert H., Bos, Peter M.J.

Volltext